Nutrafem Research & Ingredients

United Kingdom 'Quality of Life' Consumer Study Results

By simply including Nutrafem in their diet:

• 94% noted increased menopause wellbeing during the study period.
• 93% noted increased energy / reduced fatigue during the study period.
• 86% noted improved emotional wellbeing during the study period.
• 83% noted improved sleep during the study period.
• 72% noted increased social functioning,
• 79% noted decreased general bodily aches & pain,
• 64% perceived an improvement in general health and
• 57% noted a reduction in role limitation due to emotional problems.

Given the short term of the study (to 4 weeks) and the role of Nutrafem, benefits in the physical functioning and role limitation due to physical functioning sections of the RAND36 were not considered significant and additionally, results under 14% were not considered significant.

Nutrafem and Vasomotor-Related Quality of Life (under 4 weeks. n=25).

1. A. For Reference Basline and after Tx with 7b-Estradiol/NETA Greene Index. n=40. Deman RJ, et al. Int J fertil. 1995; 40:73-8

37. Hot flushes, sweating (episodes of sweating)
38. Heart discomfort (unusal awareness of heart beat, heart skipping, heart racing, tightness)
39. Sleep problems (difficulty in falling asleep, difficulty in sleeping through, waking up early)
40. Depressive mood (feeling down, sad, on the verge of tears, lack of drive, mood swings)
41. Irritability (feeling nervous, inner tension, feeling agressive)
42. Anxiety (inner restlessness, feeling panicky)
43. Physical and mental exhaustion (general decrease in performance, impaired memory, decress in concentration, forgetfulness)
44. Sexual problems (change in sexual desire, in sexual activity and satisfaction)
45. Bladder problems (difficulty in urinating, increased need to urinate, bladder incontinence)
46. Dryness of vagina (sensation of dryness of burning in the vagina, difficulty with sexual intercourse)
47. Joint and muscular discomfort (pain in the joints, rheumatoid complaints)

For the purposes of this part of the study, a conventional Menopause Rating Scale (MRS) questionnaire was used, with participants answering 11 quality of life questions via 5 possible answers - None, Mild, Moderate, Severe and Very Severe. This questionnaire was part of a larger study that examined physical and mental health via a modified RAND36 questionnaire and sleep quality va the Pittsburgh Insomnia Rating Scale. The total range of questions allowed a measure of verification between measuring methods.

Results of the Summary

Nutrafem worked quickly, with 92% of participants noting menopause related symptoms reducing in the first 3 weeks. For Hot Flushes and Night Sweats, 76% of participants appreciated an average reduction to 50% of initial number of episodes within 10 days and 34% in 3 weeks, which exceeds the mean established for conventiaonl therapy[1] (CEE/MPA) - reducing to 34% in 4 weeks.

Using Nutrafem, Quality of Life improvements are measurably greater than those offered by conventional HRT[2] witha complete absence of HRT's documented side effects. Both the improved well-being[3] and the absence of side effects, significantly increased tolerance to any residual symptoms at week 3. The final week's results compared to those established in other studies, indicating a continued improvement at week 4 and beyond. 20% of participants inducated that, initially excess wind was noticeable - this is an expected effect when adding Nutrafem (bean based) to western diets.

1. Women's HOPE study, a randomized, double-blind, placebo-controlled trial that evaluated the safety and efficacy of standard and lower-than-standard doses of CEE and CEE/MPA.
2. Women's Health Initiative (WHI): QOLEvaluation
3. Comprises: Role limitation due to physical health, Role limitation due to emotional problems, Energy / fatigue, Emotional wellbeing and Social functioning)